Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes Mellitus

In brief

The current trial will examine the efficacy and safety of Exubera administered as a mealtime insulin compared to lispro, when added to an existing regimen of basal insulin glargine + or = Oral Agents (OAs). Dose titrations will be provided which should allow a large proportion of subjects to reach target glycosylated hemoglobin (A1C) levels.

Key facts

Study ID

NCT00348374

Run by

Pfizer

People needed

191

Starts

2006-06-01

Expected to finish

2008-08-01

Last updated by the study team

2010-03-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with type 2 diabetes using Lantus® (insulin glargine) as their basal insulin, not at glycemic goal.

You may not qualify if…

• lung disease
• current smoking or discontinued smoking within past 6 months

Where it is running

• Pfizer Investigational Site — Mobile, Alabama, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Malvern, Arkansas, United States
• Pfizer Investigational Site — Foot Hill Ranch, California, United States
• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Greenbrae, California, United States
• Pfizer Investigational Site — Los Gatos, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Mateo, California, United States
• Pfizer Investigational Site — Tustin, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — New Britain, Connecticut, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Winter Park, Florida, United States
• Pfizer Investigational Site — Columbus, Georgia, United States
• Pfizer Investigational Site — Decatur, Georgia, United States
• Pfizer Investigational Site — Honolulu, Hawaii, United States
• Pfizer Investigational Site — Honululu, Hawaii, United States
• Pfizer Investigational Site — Idaho Falls, Idaho, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.